Role of interstitial brachytherapy in the treatment of malignant disease

Onkologie

Volumn 24, Issue 3, 2001, Pages 222-228

  Kolotas, C ^a   Zamboglou, N ^a  

^a Klinikum Offenbach GmbH   (Germany)

Author keywords

Brachytherapy; Breast cancer; Head and neck tumors; Prostate cancer

Indexed keywords

IRIDIUM 192; RADIOISOTOPE;

BLADDER CANCER; BRACHYTHERAPY; BRAIN CANCER; BREAST CANCER; CANCER CONTROL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HEAD AND NECK CANCER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; RADIATION DOSE; REVIEW; SOFT TISSUE SARCOMA; TREATMENT PLANNING;

BRACHYTHERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; NEOPLASMS; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL RATE;

EID: 0034913372     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055084     Document Type: Review

References (50)

1. High dose rate brachytherapy in the treatment of carcinoma of the prostate: Preliminary results
2. Brachytherapy and organ preservation in the management of carcinoma of the prostate
3. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation
4. Serum PSA after anatomic radical prostatectomy: The Johns Hopkins experience after 10 years
5. PSA levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer
6. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < 10 ng/mL: Radiation therapy or surgery
7. Definitive therapy for stage T1/T2 prostate carcinoma: PSA-based comparison between surgery, external beam, and implant radiotherapy
8. Radical radiation therapy in the management of prostatic adenocarcinoma:The initial PSA value as a predictor of treatment outcome
9. PSA and radiation therapy for clinically localised prostate cancer
10. PSA based disease control following ultrasound guided iodine-125 implantation for stage T1/T2 prostatic carcinoma
11. Short-term freedom from disease progression after I-125 prostate implantation
12. Low dose rate brachytherapy in head and neck carcinomas
13. The Paris System
14. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: A report of 1676 cases by the Groupe Europeen de Curie-therapy
15. Curietherapy of epithelioma of the external ear: A series of 140 patients
16. Radiation therapy for carcinoma of the pinna using iridium 192 wires: A series of 70 patients
17. The role of brachytherapy in treatment of head and neck cancer: Institut Gustave-Roussy experience with 1140 patients
18. Le carcinome epidermoide de la face interne de joue: A propos de 748 malades
19. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: Statistical study of a series of 207 cases
20. Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth
21. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation
22. Interstitial brachytherapy and early tongue squamous cell carcinoma management
23. Velotonsillar squamous cell carcinoma: 277 Cases treated by combined external irradiation and brachytherapy-results according to extension, localization, and dose rate
24. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin
25. Reirradiation of recurrent head and neck cancers: External and/or interstitial radiation therapy
26. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-Year results of 70 cases
27. Iridium-192 afterloaded implant in the retreatment of head and neck cancers
28. Breast conservation, the problem of treating the excision site effectively: Physical criteria for the choice of technique used
29. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique?
30. 192iridium implant) on local control and cosmesis after conservative surgery and radiation therapy
31. Biopsy and definitive radiation therapy in stage I and II adenocarcinoma of the female breast: Analysis of cosmesis and the role of electron beam supplementation
32. Primary radiation therapy for early breast cancer: The experience at the Joint Center for Radiation Therapy
33. Brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer
34. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: A pilot study
35. Brachytherapy alone in the treatment of selected patients with early stage breast cancer treated with breast conserving therapy
36. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer
37. Organ preservation in the treatment of bladder cancer
38. 137caesium needles for bladder cancer: Results for 312 patients
39. 192iridium implantation
40. Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192)
41. Afterloading in interstitial and intracavitary radiation therapy
42. Intraoperative treatment for soft tissue sarcomas
43. Long-term results of a prospective randomised trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremities and superficial trunk
44. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and the lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the Scandinavian Glioblastoma Study Group
45. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas; a cooperative clinical trial
46. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas
47. High-activity iodine-125 interstitial implant for gliomas
48. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience
49. CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas
50. CT based interstitial HDR brachytherapy